Skip to content
The Nexus
HEALTHAug 1 · 11:00 UTCNPR HEALTHSydney Lupkin

FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

The FDA is considering Moderna's mRNA-based flu shot, which could be the first of its kind. The decision may impact the biotech industry. The technology has been questioned by RFK Jr.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
FDAorganizationModernaorganizationmRNA-based flu shottopicRobert F. Kennedy Jr.personbiotech industrytopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting